In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nimodipino Drug Master File in Korea (Nimodipino KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nimodipino. The MFDS reviews the Nimodipino KDMF as part of the drug registration process and uses the information provided in the Nimodipino KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nimodipino KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nimodipino API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nimodipino suppliers with KDMF on PharmaCompass.